Cargando…
Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
Autores principales: | Povedano Panades, Mónica, Couratier, Philippe, Sidle, Katie, Sorarù, Gianni, Tsivgoulis, Georgios, Ludolph, Albert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296145/ https://www.ncbi.nlm.nih.gov/pubmed/34305774 http://dx.doi.org/10.3389/fneur.2021.633854 |
Ejemplares similares
-
Riluzole and Edavarone: The Hope Against Amyotrophic Lateral Sclerosis
por: Rokade, Aditi V, et al.
Publicado: (2022) -
Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis
por: Dyer, Ann Margaret, et al.
Publicado: (2016) -
Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
por: Introna, Alessandro, et al.
Publicado: (2018) -
Ethical Principles in Patient-Centered Medical Care to Support Quality of Life in Amyotrophic Lateral Sclerosis
por: Lulé, Dorothée, et al.
Publicado: (2019) -
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)